Dec. 6 at 2:10 AM
$APLT Applied Therapeutics is compelling because it operates in a niche but massive potential rare metabolic indication, where one safely tolerated brain-penetrant small molecule could correct toxicity, prevent long-term complications, and plausibly be priced like a functional cure.
Price target upgraded to
$10.00